Skip to main content
Premium Trial:

Request an Annual Quote

Genelabs' Affiliate Sells Shares Worth $4.3M

Premium

REDWOOD CITY, Calif.--Gene labs Technologies, a drug discovery firm headquartered here, received $4.3 million form the sale of shares in its Taiwan affiliate, Genelabs Biotechnology. A single investor, Long Bon Development, purchased the shares for $17.50 per share.

Filed under